These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

272 related articles for article (PubMed ID: 19623629)

  • 1. Dermatomyositis with inclusion body myositis pathology.
    Layzer R; Lee HS; Iverson D; Margeta M
    Muscle Nerve; 2009 Sep; 40(3):469-71. PubMed ID: 19623629
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inclusion body myositis: clinical and pathological boundaries.
    Amato AA; Gronseth GS; Jackson CE; Wolfe GI; Katz JS; Bryan WW; Barohn RJ
    Ann Neurol; 1996 Oct; 40(4):581-6. PubMed ID: 8871577
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A dual role for HSP90 and HSP70 in the inflammatory myopathies: from muscle fiber protection to active invasion by macrophages.
    De Paepe B; Creus KK; Martin JJ; Weis J; De Bleecker JL
    Ann N Y Acad Sci; 2009 Sep; 1173():463-9. PubMed ID: 19758187
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Difference in adhesion molecule expression (ICAM-1 and VCAM-1) in juvenile and adult dermatomyositis, polymyositis and inclusion body myositis.
    Sallum AM; Kiss MH; Silva CA; Wakamatsu A; Vianna MA; Sachetti S; Marie SK
    Autoimmun Rev; 2006 Feb; 5(2):93-100. PubMed ID: 16431335
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inclusion body myositis long after dermatomyositis: a report of two cases.
    McCoy AL; Bubb MR; Plotz PH; Davis JC
    Clin Exp Rheumatol; 1999; 17(2):235-9. PubMed ID: 10342053
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preservation of in vitro muscle fiber function in dermatomyositis and inclusion body myositis: a single fiber study.
    Krivickas LS; Amato AA; Krishnan G; Murray AV; Frontera WR
    Neuromuscul Disord; 2005 May; 15(5):349-54. PubMed ID: 15833427
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Inclusion body myositis associated with sacroidosis: a report of 3 cases].
    Bouillot S; Coquet M; Ferrer X; Lagueny A; Leroy JP; Vital C
    Ann Pathol; 2001 Aug; 21(4):334-6. PubMed ID: 11685131
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The practice guideline 'Dermatomyositis, polymyositis and sporadic inclusion body myositis'].
    Hoogendijk JE; Bijlsma JW; van Engelen BG; Lindeman E; van Royen-Kerkhof A; de Rie MA; de Visser M; Jennekens FG;
    Ned Tijdschr Geneeskd; 2005 Sep; 149(38):2104-11. PubMed ID: 16201600
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inflammatory myopathies: evaluation and management.
    Greenberg SA
    Semin Neurol; 2008 Apr; 28(2):241-9. PubMed ID: 18351525
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A high incidence of disease flares in an open pilot study of infliximab in patients with refractory inflammatory myopathies.
    Dastmalchi M; Grundtman C; Alexanderson H; Mavragani CP; Einarsdottir H; Helmers SB; Elvin K; Crow MK; Nennesmo I; Lundberg IE
    Ann Rheum Dis; 2008 Dec; 67(12):1670-7. PubMed ID: 18272672
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acquired immune and inflammatory myopathies: pathologic classification.
    Pestronk A
    Curr Opin Rheumatol; 2011 Nov; 23(6):595-604. PubMed ID: 21934500
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interleukin-1 expression in inflammatory myopathies: evidence of marked immunoreactivity in sarcoid granulomas and muscle fibres showing ischaemic and regenerative changes.
    Authier FJ; Mhiri C; Chazaud B; Christov C; Cherin P; Barlovatz-Meimon G; Gherardi RK
    Neuropathol Appl Neurobiol; 1997 Apr; 23(2):132-40. PubMed ID: 9160898
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Shared blood and muscle CD8+ T-cell expansions in inclusion body myositis.
    Dimitri D; Benveniste O; Dubourg O; Maisonobe T; Eymard B; Amoura Z; Jean L; Tiev K; Piette JC; Klatzmann D; Herson S; Boyer O
    Brain; 2006 Apr; 129(Pt 4):986-95. PubMed ID: 16455793
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A case of edematous dermatomyositis.
    Mroué KH; Sharara NH; Rbeiz JG; Arayssi TK
    J Rheumatol; 2003 Dec; 30(12):2722-3. PubMed ID: 14719223
    [No Abstract]   [Full Text] [Related]  

  • 15. Inclusion body myositis in connective tissue disorders: case report and review of the literature.
    Derk CT; Vivino FB; Kenyon L; Mandel S
    Clin Rheumatol; 2003 Oct; 22(4-5):324-8. PubMed ID: 14576992
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sporadic inclusion body myositis: counts of different types of abnormal fibers.
    Pruitt JN; Showalter CJ; Engel AG
    Ann Neurol; 1996 Jan; 39(1):139-43. PubMed ID: 8572661
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Therapeutic approaches in patients with inflammatory myopathies.
    Dalakas MC
    Semin Neurol; 2003 Jun; 23(2):199-206. PubMed ID: 12894385
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Histological data in inflammatory myositis].
    Mikol J; Polivka M
    Ann Med Interne (Paris); 2001 Nov; 152(7):465-79. PubMed ID: 11965088
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Light and electron microscopic immunolocalization of presenilin 1 in abnormal muscle fibers of patients with sporadic inclusion-body myositis and autosomal-recessive inclusion-body myopathy.
    Askanas V; Engel WK; Yang CC; Alvarez RB; Lee VM; Wisniewski T
    Am J Pathol; 1998 Apr; 152(4):889-95. PubMed ID: 9546349
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bilateral ocular myositis as a late complication of dermatomyositis.
    Kokotis P; Theodossiadis P; Bouros C; Sfikakis PP
    J Rheumatol; 2005 Feb; 32(2):379-81. PubMed ID: 15693104
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.